Methods rat model of alcoholic liver disease were established by alcohol administration.
方法酒精灌胃法制备大鼠酒精性肝病模型。
ObjectiveTo evaluate the efficacy and safety of Metadoxine in treatment of alcoholic liver disease.
目的评价美他多辛片治疗酒精性肝病的临床疗效和安全性。
Objective To search a simple and reliable method for establishing an alcoholic liver disease model in rats.
目的寻找一种简单可靠的方法制作大鼠慢性酒精性肝病模型。
Objective: To observe the therapeutic effects and the reliability of Canle on alcoholic liver disease (ALD).
目的：观察甘乐对酒精性肝病的疗效和安全性。
Objective To evaluate the efficacy and safety of Capsule metadoxine in the treatment of alcoholic liver disease.
目的观察美他多辛胶囊治疗酒精性肝病的临床疗效和安全性。
Objective To explore the effect of cyclooxygenase 2 (COX-2) in the pathogenesis of alcoholic liver disease (ALD).
目的探讨环氧合酶2 (COX - 2)在酒精性肝病(ALD)发病机制中的作用。
Objective To study the relation of serum leptin and liver function in patients with alcoholic liver disease (ALD).
目的探讨瘦素在酒精性肝病(ALD)及不同阶段中的变化规律及其与肝功能受损的关系。
Objective: To explore the effect and safety of tetramethylpyrazine combined glutathione on alcoholic liver disease.
目的：探讨川芎嗪联合谷胱甘肽对酒精性肝病的疗效及安全性。
Conclusion: In rats with alcoholic liver disease, BFGF is highly expressed, and KXI could decrease BFGF expression.
结论：在酒精性肝病BFGF的表达增强，抗纤复方I号能降低其表达。
We observed three patients with alcoholic liver disease, suffering from severe hemolytic anemia, requiring multiple blood transfusions.
我们描述了例酒精性肝病患者并发严重溶血性贫血，需要多次输血。
To evaluate the efficacy of diisopropylamine dichloroacetate (Ganle) injection on chronic hepatitis companied with alcoholic liver disease.
观察应用复方二氯醋酸二异丙胺治疗慢性病毒性肝炎合并酒精性肝损伤的临床疗效。
Objective To investigate the role of hepatic and gastric alcohol dehydrogenases (ADH) in different pathologic stages of alcoholic liver disease (ALD).
目的探讨肝、胃乙醇脱氢酶（ADH）活性的变化在酒精性肝病（ALD）不同病理阶段中的作用。
Alcoholic liver disease has become the main cause of liver injury following the virus hepatitis, and its prevention and cure has become an important medical task.
酒精性肝损伤已成为继病毒性肝炎后的主要肝损伤病因，因此酒精性肝病的防治已经成为重要的医疗课题。
Objective: To observe the effect of Qinggan Huoxue Decoction on gene expression of key enzyme about alcohol metabolism of Wistar rat with alcoholic liver disease (ALD).
目的：观察清肝活血方对酒精性肝病大鼠乙醇代谢关键酶基因表达的影响。
Objective: To find measures for decreasing morbidity of alcoholic liver disease (ALD) by evaluating its incidence, clinical manifestations and prognosis in recent years.
目的探讨近几年来酒精性肝病(ALD)的发病情况、临床表现及预后，寻找对应措施降低发病率。
Objective: To study the efficacy of domestic reduced glutathione vial for injection in comparison with imported Gluthion in treatment of chronic alcoholic liver disease (CALD).
目的：初步验证古拉定(国产注射用还原型谷胱甘肽)对酒精性肝病的疗效。
We and others have pointed this out recently for several liver diseases, including chronic viral hepatitis B and c, alcoholic liver disease, and non-alcoholic fatty liver disease.
我们及其他研究者最近得出的这一结论适用于多种肝脏疾病，包括乙型慢性病毒性肝炎、丙型慢性病毒性肝炎、酒精性肝病和非酒精性脂肪肝。
Objective: To investigate the expression of basic fibroblast growth factor (BFGF) in rats with alcoholic liver disease and the effect of Kangxian Fufang I (KXI) on BFGF expression.
目的：探讨碱性成纤维细胞生长因子（BFGF）在酒精性肝病大鼠肝脏中的表达及抗纤复方I号对其表达的影响。
HBV infection may be a positive risk factor for alcoholic liver disease. However, little is still known about the relationship between HBV gene mutation and habitual alcohol intake.
同时探讨了乙肝病毒感染对酒精性肝病易感性的影响，证实乙肝病毒感染是酒精性肝病的正性危险因素，但目前关于酒精对乙肝病毒变异影响的研究较少。
Conclusion The different alcoholic liver disease phases were stimulated by 50% alcohol for different times, which could be applied in screening health foods for protecting alcohol injury.
结论选择50%的乙醇灌胃不同时间，模拟酒精性肝损伤的不同阶段，可将该模型应用于保健食品护肝功能的筛选。
UCP2 is associated with energy expenditure and lipid metabolism. It can take part in the process of oxidative stress and lipid peroxidation in the pathogenesis of alcoholic liver disease (ALD).
UCP2与能量消耗和脂质代谢密切相关，可能参与酒精性肝病(ALD)发病过程中的氧化应激和脂质过氧化。
Objective: To investigate the incidence of alcoholic liver disease (ALD) in recent years, as well as clinical manifestations and prognosis, and to find corresponding measures to reduce the morbidity.
目的探讨近几年来酒精性肝病（ALD）的发病情况、临床表现及预后，寻找对应措施降低发病率。
In fact, interleukin-1 in this scenario can induce fat deposition in the hepatocytes which is one of the characteristics on non-alcoholic fatty liver disease.
事实上，白细胞介素- 1在这种情况下可以诱导肝细胞脂肪沉积，这是非酒精性脂肪性肝病的一个特征。
In contrast, EPA offered only partial protection against CLA-induced non-alcoholic fatty liver disease and provided no protection against insulin resistance.
相比之下，EPA只是提供了部分性的保护作用预防CLA诱导的非酒精性脂肪肝病，而对胰岛素抵抗未提供保护作用。
Non-alcoholic fatty liver disease (NAFLD) is regarded as a manifestation of metabolic syndrome in the liver.
非酒精性脂肪肝被认为是肝的代谢综合症的表现。
Non-alcoholic fatty liver disease can result in cirrhosis of the liver or liver cancer.
非酒精性脂肪肝病能够导致肝硬化或肝癌。
This is one side of our better understanding in recent studies of non-alcoholic fatty liver disease.
这是我们对非酒精性脂肪肝理解更深入的一个方面。
I believe that when you look at non-alcoholic fatty liver disease you are dealing with a spectrum of different diseases.
我认为当我们在研究非酒精性脂肪肝时，我们面对的是不同疾病的疾病谱。
Objective To study the pathogenesis of non alcoholic fatty liver disease (NAFLD) and the efficacy and safety of Orlistat plus low caroli diet in the treatment of NAFLD.
目的探讨非酒精性脂肪性肝病(NAFLD)的发病机制及奥利司他结合低热量饮食治疗对NAFLD的有效性和安全性。
Objective To study the pathogenesis of non alcoholic fatty liver disease (NAFLD) and the efficacy and safety of Orlistat plus low caroli diet in the treatment of NAFLD.
目的探讨非酒精性脂肪性肝病(NAFLD)的发病机制及奥利司他结合低热量饮食治疗对NAFLD的有效性和安全性。
应用推荐